Search results (799)
« Back to NewsRenewal of the Novo Nordisk – University of Oxford Fellowship Programme
2 December 2024
Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.
Davis Group receives Wellcome Discovery Award
2 December 2024
Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled “Small contacts, big decisions – early signal processing by T cells”. This has been awarded jointly with Professor Anna Lippert of the University of Würzburg.
RDM researcher receives award for research shedding light on microstructural and metabolic differences in hypertrophic cardiomyopathy patients
26 November 2024
Congratulations to Dr Zakariye Ashkir who received the Best Scientific Abstract Award from the Association of Inherited Cardiac Conditions at their Annual Conference held in Cambridge earlier this month.
RDM researchers at IF Oxford Science and Ideas Festival
19 November 2024
Researchers from RDM’s Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and the MRC Weatherall Institute of Molecular Medicine (WIMM) took centre stage at this year's IF Oxford Science and Ideas Festival with some exciting and interactive public engagement activities.
Peruvian interns gain invaluable research experience in RDM
18 November 2024
Two interns who have recently graduated from the Research Experience for Peruvian Undergraduates (REPU) have described how their experience of working alongside RDM researchers has opened doors to new opportunities.
Transformative treatments for children with fatal genetic lung diseases
15 November 2024
AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.
Launch of the new BHF Oxford Centre of Research Excellence
14 November 2024
Celebrating a £5million British Heart Foundation renewal award to the University of Oxford to advance cardiovascular science.
Under-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population
24 October 2024
DTU General OCDEM Publication Research
People diagnosed with type 2 diabetes before 40 years of age, have nearly four times the risk of death compared with the general UK population, a new study carried out at the University of Oxford’s Radcliffe Department of Medicine has found.
35 Years of the MRC WIMM
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs
22 October 2024
Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.
Professor Robin Choudhury publishes a new book about the heart
17 October 2024
Robin Choudhury, Professor of Cardiovascular Medicine, has written a book about the art and science of the heart. Here he answers some questions about the origins and highlights of the project.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
Researchers develop new tool to better predict acute myeloid leukaemia outcomes in older patients
17 September 2024
General MRC MHU MRC WIMM Publication Research
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
Hydroxychloroquine provides moderate COVID-19 prevention
16 September 2024
COPCOV, the world’s largest COVID-19 chemoprevention study, published results today showing that hydroxychloroquine (HCQ) has a moderate benefit in preventing COVID-19. The COPCOV trial was led globally by the Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand. The Diabetes Trials Unit (DTU) was the UK coordinating centre for the trial, helped develop the protocol, and was responsible for managing UK sites, approvals and procedures.
Patients receiving steroids are more than twice as likely to develop diabetes, UK study has found
10 September 2024
Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, a new study by researchers at the Radcliffe Department of Medicine’s Diabetes Trial Unit has found.
RDM researchers among world-leading cardiologists at ESC Congress 2024
29 August 2024
World-leading cardiology experts are to convene at the annual European Society of Cardiology (ESC) Congress in London from tomorrow (Friday 30 August).
Senior Fellowship awarded to Beth Psaila
28 August 2024
Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.
Michael Zimmermann awarded Full Professor title
27 August 2024
Congratulations to Professor Michael Zimmermann, who has been awarded the title of Full Professor in the University’s 2024 Recognition of Distinction exercise.
Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes
27 August 2024
General MRC MHU MRC WIMM Publication Research
Researchers from the MRC Weatherall Institute of Molecular Medicine (WIMM) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.